PLATINEA: Platform for Innovation of Existing Antibiotics
This collaborative platform innovation project aims to improve access to and use of antibiotics in Swedish healhcare. The project assembles 14 stakeholder parties from university, public agencies and industry
Running time: 2019-2020. Funder: VINNOVA (SEK 20M). Lead PI: Enrico Baraldi (Uppsala University) + several Uppsala-based researchers and healthcare practitioners. CARe co-PI: Christian Munthe, CARe research assistant: Erik Malmqvist.
This collaborative platform innovation project aims to improve access to and use of antibiotics in Swedish healhcare. The project assembles 14 stakeholder parties from university, public agencies and industry, and is organized in four work packages:
WP1: Continuous priority setting of national needs of antibiotics and related knowledge gaps
WP2: Implementation studies of new methods for rational handling of antibiotics
WP3: Knowledge-producing studies on optimizing the use of antibiotics
WP4: Analysis, mapping and discussion of production and delivery chains and economic models for improved sustainable access
CARe-partners are especially active in WP4 regarding possible actions to stimulate increased transparency and sustainability regarding pollution from antibiotic production, as well as policy actions to stimulate innovation, but may also assist with ethical competence in WP2, as implementing antibiotic stewardship actions may often actualize ethical challenges.
Other project participants: Åsa Ahlenbäck (Östergötland County Government), Lisa Bandholtz (Swedish Pharmacy Society), Sandra K.Bark (MSD pharmaceutical AB), Charlotta Edlund (Swedish Public Health Agency) Margareta Eriksson + others (Karolinska University hospital), Patriq Fagerstedt (Swedish Research Council, VR), Christian Gieske + others (Karolinksa institutet), Håkan Hanberger (Linköping University), Douglas Lundin (Dental and Pharmaceutical Benefits Agency), Bengt Mattson (Swedish Association of Pharmacological Industry, LIF), Magnus Munge (Kronoberg County Government), Johan Ohlson (Meda AB), Fredrik Resman (Skåne County Government), Christine Årdal (Norwegian Institute of Public Health)